文献速递衰弱、肌少症与跌倒

老年肌少症干预措施:随机对照研究的系统综述与荟萃分析

Interventions for Treating Sarcopenia: A Systematic Review and Meta-Analysis of Randomized Controlled Studies.
PubMed 文献 · J Am Med Dir Assoc · 2017-01-01

证据质量极低至低,提示运动干预3个月可能改善肌肉质量、力量和步行速度,营养干预3个月可能改善肌肉力量,选择性雄激素受体调节剂对肌肉质量、力量和躯体功能无明确效果,运动联合营养干预3个月可能改善步行速度。

要点

  • 运动干预3个月可能改善老年肌少症患者的肌肉质量、力量和步行速度。
  • 营养干预3个月可能改善老年肌少症患者的肌肉力量。
  • 选择性雄激素受体调节剂对肌肉质量、力量和躯体功能无明确效果。

核心结论

  • 运动与营养干预对治疗老年肌少症显示一定积极效果,但证据质量低。

研究设计与样本

  • 共筛选2668条记录,纳入7项RCT,涉及运动(4项RCT)、营养(5项RCT)、药物(1项RCT)和联合干预(4项RCT)。

主要发现

  • 极低至低质量证据提示运动干预3个月可能改善肌肉质量、肌肉力量和步行速度。
  • 极低至低质量证据提示营养干预3个月可能有效改善肌肉力量。
  • 作为药物干预,选择性雄激素受体调节剂对肌肉质量、力量和躯体功能无明确效果。
  • 运动联合营养干预3个月可能对改善步行速度有积极效果。

关键数值与推荐

  • 运动干预3个月可能改善肌肉质量、肌肉力量和步行速度(证据质量极低至低)。
  • 营养干预3个月可能改善肌肉力量(证据质量极低至低)。
  • 选择性雄激素受体调节剂对肌肉质量、力量和躯体功能无明确效果(证据质量极低至低)。
  • 运动联合营养干预3个月可能改善步行速度(证据质量极低至低)。

临床怎么用

  • 对老年肌少症患者可考虑运动干预以改善肌肉质量、力量和步行速度,但需知晓证据质量低。
  • 营养干预可作为改善肌肉力量的措施之一,但证据质量低。
  • 不推荐选择性雄激素受体调节剂用于改善肌少症患者的肌肉质量、力量和躯体功能,因其无明确效果。
  • 运动联合营养干预可能有助于改善步行速度,可作为综合管理的一部分。

局限性

  • 纳入研究数量少(仅7项RCT),证据质量极低至低。
  • 需要未来高质量RCT来强化结果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Much interest has been focused on interventions for treating sarcopenia; however, the effects have gained little evidence. OBJECTIVE: To analyze the effectiveness of exercise, nutritional, drug, and combinational interventions for treating sarcopenia in older people. METHOD: We systematically searched MEDLINE via PubMed, the Cochrane Library of Cochrane Reviews and Cochrane Central Register of Controlled Trials, and Ichushi-Web for randomized controlled trials (RCTs) from January 2000 to December 2016. We have assessed the type of intervention, the cohort used, the way sarcopenia was diagnosed, the outcomes, and the quality of evidence. We meta-analyzed the outcomes with the net difference between-group treatment from baseline to the end of the study. RESULTS: We screened a total of 2668 records and included seven RCTs that investigated the effects of exercise (4 RCTs), nutrition (5 RCTs), drug (1 RCT), and combination (4 RCTs) on muscle mass, strength, and function in older people with sarcopenia. Very low to low-quality evidence suggests that (1) exercise interventions may play a role in improving muscle mass, muscle strength, and walking speed in 3 months of intervention; (2) nutritional interventions may be effective in improving muscle strength in 3 months of intervention; (3) as drug intervention, selective androgen receptor modulator had no clear effect on muscle mass, strength, and physical function; and (4) a combined intervention of exercise and nutrition may have positive effects in improving the walking speed in 3 months of intervention. CONCLUSION: Our systematic review and meta-analysis showed some positive effects of exercise and nutritional interventions for treating sarcopenia in older people, although the quality of the evidence was low. Future high-quality RCTs should be implemented to strengthen the results.

来源:J Am Med Dir Assoc,查看原文。版权归原作者所有。

引用

  1. Yoshimura Y, Wakabayashi H, Yamada M, et al. Interventions for Treating Sarcopenia: A Systematic Review and Meta-Analysis of Randomized Controlled Studies. J Am Med Dir Assoc. 2017. PMID: 28549707. doi:10.1016/j.jamda.2017.03.019

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。